These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 24906174

  • 21. Lercanidipine, enalapril and their combination in the treatment of elderly hypertensive patients: placebo-controlled, randomized, crossover study with four ABPM.
    Puig JG, Calvo C, Luurila O, Luurila H, Sulosaari S, Strandberg A, Ghezzi C.
    J Hum Hypertens; 2007 Dec; 21(12):917-24. PubMed ID: 17581601
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension.
    Applegate WB, Cohen JD, Wolfson P, Davis A, Green S.
    Am J Cardiol; 1996 Jul 01; 78(1):51-5. PubMed ID: 8712118
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C, Haller H, Menne J.
    Expert Opin Pharmacother; 2009 Aug 01; 10(11):1833-40. PubMed ID: 19527194
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of lercanidipine/enalapril fixed combination in Lebanon: a prospective observational study.
    Arnaout S, DUAL Investigators Study Group.
    Curr Med Res Opin; 2015 Jan 01; 31(1):187-90. PubMed ID: 25424779
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P, Fuchs FD, Moreira LM, Martins VM, Bertoluci C, Fuchs SC, Gus M.
    Clin Exp Hypertens; 2008 Oct 01; 30(7):553-64. PubMed ID: 18855259
    [Abstract] [Full Text] [Related]

  • 28. Antihypertensive efficacy and safety of manidipine versus amlodipine in elderly subjects with isolated systolic hypertension: MAISH study.
    Payeras AC, Sladek K, Lembo G, Alberici M.
    Clin Drug Investig; 2007 Oct 01; 27(9):623-32. PubMed ID: 17705571
    [Abstract] [Full Text] [Related]

  • 29. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension.
    De Ciuceis C, Salvetti M, Rossini C, Muiesan ML, Paini A, Duse S, La Boria E, Semeraro F, Cancarini A, Rosei CA, Sarkar A, Ruggeri G, Caimi L, Ricotta D, Rizzoni D, Rosei EA.
    J Hypertens; 2014 Mar 01; 32(3):565-74. PubMed ID: 24378999
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep 01; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 32. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ, Stapff M, Lin Y.
    Am J Cardiovasc Drugs; 2013 Apr 01; 13(2):129-40. PubMed ID: 23519546
    [Abstract] [Full Text] [Related]

  • 33. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome.
    Ghiadoni L, Bruno RM, Cartoni G, Stea F, Magagna A, Virdis A, Grassi D, Ferri C, Taddei S.
    Vascul Pharmacol; 2017 May 01; 92():16-21. PubMed ID: 26070528
    [Abstract] [Full Text] [Related]

  • 34. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ, Nanivadekar AS.
    J Assoc Physicians India; 1998 May 01; Suppl 1():52-62. PubMed ID: 11233387
    [Abstract] [Full Text] [Related]

  • 35. Dose response and safety of telmisartan in patients with mild to moderate hypertension.
    Smith DH, Matzek KM, Kempthorne-Rawson J.
    J Clin Pharmacol; 2000 Dec 01; 40(12 Pt 1):1380-90. PubMed ID: 11185637
    [Abstract] [Full Text] [Related]

  • 36. Comparison of the efficacy and tolerability of telmisartan 40 mg vs. enalapril 10 mg in the treatment of mild-to-moderate hypertension: a multicentre, double-blind study in Taiwanese patients.
    Chen JH, Cheng JJ, Chen CY, Chiou HC, Huang TY, Tsai CD, Fu MM, Cherng WJ.
    Int J Clin Pract Suppl; 2004 Dec 01; (145):29-34. PubMed ID: 15617456
    [Abstract] [Full Text] [Related]

  • 37. Placebo-controlled comparison of the efficacy and tolerability of once-daily moxonidine and enalapril in mild-to-moderate essential hypertension.
    Küppers HE, Jäger BA, Luszick JH, Gräve MA, Hughes PR, Kaan EC.
    J Hypertens; 1997 Jan 01; 15(1):93-7. PubMed ID: 9050976
    [Abstract] [Full Text] [Related]

  • 38. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C, Stabouli S, Kotsis V.
    Vasc Health Risk Manag; 2016 Jan 01; 12():443-451. PubMed ID: 27895487
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the fixed combination of enalapril/diltiazem ER and their monotherapies in stage 1 to 3 essential hypertension.
    Cushman WC, Cohen JD, Jones RP, Marbury TC, Rhoades RB, Smith LK.
    Am J Hypertens; 1998 Jan 01; 11(1 Pt 1):23-30. PubMed ID: 9504446
    [Abstract] [Full Text] [Related]

  • 40. Fixed combinations in the management of hypertension: perspectives on lercanidipine-enalapril.
    Barrios V, Escobar C, Echarri R.
    Vasc Health Risk Manag; 2008 Jan 01; 4(4):847-53. PubMed ID: 19066001
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.